Recent studies indicate that the expression of PD-1 is increased in tumor-associated CD8 T cells of patients with COPD and that the sensitivity to PD-1 blockade is increased in lung cancer patients with COPD20,23,24. Here, CD8A is linked to chronic obstructive pulmonary disease.